A Guide to Biomarkers for Adults
Biomarker testing forms the foundation of evidence-based longevity medicine. Dr. Charles Kamen, MD, board-certified neurologist at LiveNow Longevity in Las Vegas, uses comprehensive biomarker panels to guide personalized interventions. Individual results vary with any health optimization approach.
What Are Biomarkers in Longevity Medicine
Biomarkers are measurable biological indicators that reflect health status, aging processes, and disease risk. In longevity medicine, specific biomarkers correlate with biological aging rate, metabolic health, and intervention effectiveness. [1]
Dr. Kamen interprets biomarker panels to identify modifiable risk factors and guide targeted therapeutic interventions at our Las Vegas longevity clinic.
Core Biomarker Categories
Comprehensive longevity biomarker assessment includes multiple categories:
- Metabolic markers: Fasting glucose, HbA1c, insulin, lipid panel
- Inflammatory markers: hs-CRP, homocysteine, ferritin
- Hormonal markers: Testosterone, estrogen, DHEA-S, cortisol
- Nutritional markers: Vitamin D, B12, folate, zinc, magnesium
- Oxidative stress markers: Glutathione, oxidized LDL
- Organ function markers: CMP, creatinine, liver enzymes
Key Aging Biomarkers
Specific biomarkers provide insight into biological aging processes:
- Hemoglobin A1c: Reflects average blood sugar over 90-120 days; elevated levels indicate metabolic dysfunction
- hs-CRP: High-sensitivity C-reactive protein measures systemic inflammation; elevated in chronic disease states
- Homocysteine: Amino acid elevated in B-vitamin deficiency and cardiovascular risk
- Insulin: Fasting insulin reflects insulin sensitivity and metabolic health
- Vitamin D: Deficiency associated with immune dysfunction, cardiovascular risk, and mortality
Interpretation and Action
Biomarker values alone are insufficient — clinical interpretation determines actionability. Dr. Kamen evaluates biomarker patterns in the context of individual history, symptoms, and goals to develop targeted intervention plans. [2]
Frequency of Testing
Dr. Kamen recommends initial comprehensive panels followed by targeted reassessment:
- Initial panel: full biomarker assessment establishes baseline
- 3-6 month recheck: for actively treated conditions or interventions
- Annual monitoring: for stable, optimal biomarkers
- Dynamic testing: more frequent for rapidly changing or concerning values
Key Takeaways
- Biomarkers provide measurable insight into biological aging and health status
- Comprehensive panels identify modifiable risk factors before disease develops
- Interpretation in clinical context determines actionable interventions
- Regular monitoring tracks intervention effectiveness
- Dr. Kamen uses biomarker data to personalize longevity protocols
- Individual results vary based on genetic and lifestyle factors
Common Questions
What biomarkers does Dr. Kamen test for longevity?
Dr. Kamen orders comprehensive panels including metabolic, inflammatory, hormonal, and nutritional markers. Specific testing is individualized based on your history and goals.
How often should I have biomarker testing?
Initial comprehensive testing is followed by 3-12 month reassessment depending on your baseline and treatment protocols. Dr. Kamen determines appropriate timing.
Do biomarkers actually predict longevity?
Certain biomarkers correlate with aging rate and disease risk, but they are one component of a comprehensive assessment. Individual results vary.
Are biomarker tests covered by insurance?
Many biomarker tests are covered with appropriate medical indication. Our staff can help verify coverage during your consultation.
What happens if my biomarkers are abnormal?
Dr. Kamen develops individualized intervention plans to address abnormal biomarkers through lifestyle, supplementation, medication, or other appropriate therapies.
Can I optimize biomarkers without medication?
Many biomarkers improve with lifestyle modification — nutrition, exercise, sleep optimization, and stress management. Dr. Kamen prioritizes non-pharmaceutical approaches when appropriate.
Comprehensive biomarker assessment is essential for evidence-based longevity medicine. Schedule a consultation with Dr. Kamen to establish your biomarker baseline and develop a personalized longevity protocol.
References
- Justice JN, et al. J Gerontol A Biol Sci Med Sci. 2024;79(3):glad245.
- Le Couteur DG, et al. Nat Med. 2023;29(7):1626-1638.
- Ahmad MI, et al. Aging Cell. 2024;23(2):e14123.
- Schneider JL, et al. Cell. 2024;187(12):2945-2968.